Neoplastic Syndromes, Hereditary
"Neoplastic Syndromes, Hereditary" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The condition of a pattern of malignancies within a family, but not every individual's necessarily having the same neoplasm. Characteristically the tumor tends to occur at an earlier than average age, individuals may have more than one primary tumor, the tumors may be multicentric, usually more than 25 percent of the individuals in direct lineal descent from the proband are affected, and the cancer predisposition in these families behaves as an autosomal dominant trait with about 60 percent penetrance.
| Descriptor ID |
D009386
|
| MeSH Number(s) |
C04.700 C16.320.700
|
| Concept/Terms |
Neoplastic Syndromes, Hereditary- Neoplastic Syndromes, Hereditary
- Hereditary Neoplastic Syndromes
- Hereditary Neoplastic Syndrome
- Neoplastic Syndrome, Hereditary
- Syndrome, Hereditary Neoplastic
- Syndromes, Hereditary Neoplastic
- Hereditary Cancer Syndromes
- Cancer Syndrome, Hereditary
- Hereditary Cancer Syndrome
- Syndrome, Hereditary Cancer
- Syndromes, Hereditary Cancer
- Cancer Syndromes, Hereditary
|
Below are MeSH descriptors whose meaning is more general than "Neoplastic Syndromes, Hereditary".
Below are MeSH descriptors whose meaning is more specific than "Neoplastic Syndromes, Hereditary".
This graph shows the total number of publications written about "Neoplastic Syndromes, Hereditary" by people in this website by year, and whether "Neoplastic Syndromes, Hereditary" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 1 | 2 |
| 1995 | 1 | 0 | 1 |
| 1996 | 1 | 0 | 1 |
| 1997 | 0 | 1 | 1 |
| 1998 | 3 | 1 | 4 |
| 1999 | 0 | 1 | 1 |
| 2000 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2003 | 3 | 1 | 4 |
| 2004 | 0 | 1 | 1 |
| 2005 | 2 | 2 | 4 |
| 2006 | 3 | 0 | 3 |
| 2007 | 4 | 1 | 5 |
| 2008 | 3 | 2 | 5 |
| 2009 | 4 | 0 | 4 |
| 2010 | 1 | 0 | 1 |
| 2011 | 2 | 1 | 3 |
| 2012 | 1 | 0 | 1 |
| 2013 | 4 | 0 | 4 |
| 2014 | 4 | 1 | 5 |
| 2015 | 2 | 1 | 3 |
| 2016 | 2 | 1 | 3 |
| 2017 | 7 | 0 | 7 |
| 2018 | 3 | 1 | 4 |
| 2019 | 10 | 1 | 11 |
| 2020 | 3 | 1 | 4 |
| 2021 | 4 | 0 | 4 |
| 2022 | 5 | 2 | 7 |
| 2023 | 2 | 0 | 2 |
| 2024 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplastic Syndromes, Hereditary" by people in Profiles.
-
The effects of oxaliplatin-based?adjuvant?chemotherapy?in?high-risk?stage?II?colon?cancer with mismatch repair-deficient: a retrospective study. BMC Cancer. 2024 Feb 02; 24(1):164.
-
Impact of tissue-agnostic approvals on management of primary brain tumors. Trends Cancer. 2024 Mar; 10(3):256-274.
-
Immunotherapy in mismatch repair-deficient metastatic colorectal cancer - Outcome and novel predictive markers. Eur J Cancer. 2024 Feb; 198:113495.
-
Obesity is associated with improved progression-free survival in Microsatellite-Instability-High endometrial cancer treated with pembrolizumab. Gynecol Oncol. 2024 Jan; 180:139-145.
-
Prevalence of Mismatch-Repair Deficiency in Rectal Adenocarcinomas. N Engl J Med. 2022 11 03; 387(18):1714-1716.
-
Clinical and molecular features of pediatric cancer patients with Lynch syndrome. Pediatr Blood Cancer. 2022 11; 69(11):e29859.
-
FOCAD Indel in a Family With Juvenile Polyposis Syndrome. J Pediatr Gastroenterol Nutr. 2022 07 01; 75(1):56-58.
-
Association of Pathogenic Variants in Hereditary Cancer Genes With Multiple Diseases. JAMA Oncol. 2022 06 01; 8(6):835-844.
-
B2M and JAK1/2-mutated MSI-H Colorectal Carcinomas Can Benefit From Anti-PD-1 Therapy. J Immunother. 2022 05 01; 45(4):187-193.
-
Current Systemic Treatments for the Hereditary Cancer Syndromes: Drug Development in Light of Genomic Defects. Am Soc Clin Oncol Educ Book. 2022 Apr; 42:1-17.